Journal article
Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors
Abstract
Commentary on: KonstamMANeatonJDDicksteinK. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 2009;374:1840–8.
Authors
McKelvie R
Journal
BMJ Evidence-Based Medicine, Vol. 15, No. 2,
Publisher
BMJ
Publication Date
April 2010
DOI
10.1136/ebm1051
ISSN
2515-446X